FIGURE 4.
Quantification of intestinal transit. (A) Normal illumination mode, (B) fluorescent mode, and (C) merge of intestinal transit from one control mouse as a representative image. (D–J) GI motility in vivo was assessed by the intestinal distribution of non-absorbable fluorescein-labeled dextran (FD70). (D) At week 4, (G) week 8, and (I) week 15, the distribution patterns of FD70 was plotted in a histogram, indicating results from each group. (E) At week 4, (H) week 8, and (J) week 15, the geometric center (GC) of the mice are depicted using a histogram. (F) The histological findings of ileoileal intussusception in one mouse treated with peptide 1 on day 30 are shown. (K) The distribution patterns of FD70 of the three groups are plotted in a histogram, and (L) the GC values of the three groups are shown in a histogram. The fluorescent intensity for the entire GI tract was calculated using ImageJ 1.52a. Data are expressed as the percentage of fluorescence intensity per segment of 14 parts (stom, stomach; sb, small bowel segments 1–10; cecum, col, colon segments 1–2) and is plotted in a histogram. The GC was calculated using the following formula: S (% FD70 per segment × segment number)/100. Asterisk denotes statistical significance.
